Evaluating a novel diagnostic test for the detection of Plasmodium infections at community level in The Gambia and Burkina Faso
Not Applicable
- Conditions
- Diagnosis of Plasmodium infectionInfections and Infestations
- Registration Number
- ISRCTN15263932
- Lead Sponsor
- MRC Unit The Gambia at LSHTM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1900
Inclusion Criteria
1. >6 months of age
2. Present in the household at the time of the interviews
3. Consent to participate in the study (or consent given by an adult caregiver if <18 years old and assent for children =12 years old)
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic accuracy of Dragonfly in detecting Plasmodium infection at the time of recruitment assessed by comparing Dragonfly results against reference standard (PCR).
- Secondary Outcome Measures
Name Time Method 1. Diagnostic accuracy of RDT in detecting Plasmodium infection at the time of recruitment by comparing RDT results against reference standard (PCR). <br>2. Diagnostic accuracy of microscopy in detecting Plasmodium infection at the time of recruitment by comparing microscopy results against reference standard (PCR). <br>3. Ease of use of Dragonfly assessed using qualitative interview guides within 4 weeks after presentation of Dragonfly technology to the potential users. <br>4. Factors influencing the uptake of community-based interventions such as mass testing and treatment assessed using qualitative interview guides within 6 months after the cross-sectional surveys.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets does the novel Plasmodium diagnostic test in ISRCTN15263932 utilize for detection?
How does the ISRCTN15263932 diagnostic test compare to rapid diagnostic tests (RDTs) and microscopy in malaria-endemic regions?
What biomarkers are being evaluated in ISRCTN15263932 to improve community-level Plasmodium infection screening accuracy?
What are the potential limitations or challenges in implementing the ISRCTN15263932 diagnostic approach in low-resource settings?
Are there any novel compounds or combination diagnostic strategies being explored alongside ISRCTN15263932 for malaria detection?